Drug Name R.COVI COVID-19 Vaccine Drug Class Risk minimization type Direct Healthcare Professional Communication DHPC Specialty (Theraputic area) Risk R-COVI/COVID-19 Vaccine AstraZeneca: contraindication in individuals with previous capillary leak syndrome Dear Healthcare provider letter DHPC